Zevra Therapeutics, Inc. (ZVRA)
8.585
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 14:36
Zevra Therapeutics Profit Margin (Quarterly): -2.09% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -301.3% |
| XOMA Royalty Corp. | -- |
| Akebia Therapeutics, Inc. | 0.92% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 44.06% |
| Return on Assets | 16.53% |
| Return on Invested Capital | 24.95% |
| Gross Profit Margin (Quarterly) | 94.04% |
| Operating Margin (Quarterly) | 15.90% |
| Return on Net Operating Assets | 54.28% |